Ritholtz Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$274K Buy
8,283
+2,150
+35% +$91K ﹤0.01% 1018
2025
Q4
$284K Sell
6,133
-212
-3% -$8.87K 0.01% 919
2025
Q3
$222K Sell
6,345
-1,933
-23% -$67.2K ﹤0.01% 941
2025
Q2
$245K Sell
8,278
-23,830
-74% -$680K 0.01% 862
2025
Q1
$958K Sell
32,108
-1,676
-5% -$51.2K 0.03% 411
2024
Q4
$968K Sell
33,784
-10,405
-24% -$344K 0.03% 367
2024
Q3
$1.71M Buy
44,189
+5,333
+14% +$190K 0.05% 260
2024
Q2
$1.25M Buy
38,856
+11,699
+43% +$406K 0.04% 296
2024
Q1
$1.05M Buy
27,157
+17,872
+192% +$625K 0.04% 346
2023
Q4
$286K Buy
+9,285
New +$233K 0.01% 611
2023
Q2
Sell
-10,363
Closed -$249K 674
2023
Q1
$249K Buy
+10,363
New +$275K 0.01% 563

Other funds holding COLL